Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-22 to 2024-02-12
Current total value of award: $45648.3
Description: 4563452855!XOLAIR 150 MG/ML SYRINGEML